Form 8-K - Current report:
SEC Accession No. 0001193125-24-197971
Filing Date
2024-08-09
Accepted
2024-08-09 17:23:03
Documents
17
Period of Report
2024-08-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d823291d8k.htm   iXBRL 8-K 33419
2 EX-1.1 d823291dex11.htm EX-1.1 209802
3 EX-5.1 d823291dex51.htm EX-5.1 49755
8 GRAPHIC g823291g0229003537659.jpg GRAPHIC 1561
  Complete submission text file 0001193125-24-197971.txt   530730

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nams-20240809.xsd EX-101.SCH 3567
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nams-20240809_def.xml EX-101.DEF 14182
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nams-20240809_lab.xml EX-101.LAB 23098
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nams-20240809_pre.xml EX-101.PRE 15030
19 EXTRACTED XBRL INSTANCE DOCUMENT d823291d8k_htm.xml XML 5851
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 241194084
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)